“Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria

[1] Grant RM(2010)Preexposure chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men N Engl J Med 363 2587-99

[2] Lama JR(2012)Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women N Engl J Med 367 399-410

[3] Anderson PL(2012)Antiretroviral Pre-exposure Prophylaxis for Heterosexual HIV Transmission in Botswana N Engl J Med 367 423-34

[4] McMahan V(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo controlled phase 3 trial Lancet 381 2083-90

[5] Liu AY(2011)Prevention of HIV-1 Infection with Early Antiretroviral Therapy N Engl J Med 365 493-505

[6] Vargas L(2012)A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: Should we be alarmed? Drug Alcohol Depend 127 65-71

[7] Baeten JM(2006)HIV status of partners of HIV positive pregnant women in different regions of Nigeria: matters arising Afr J Med Med Sci 35 125-9

[8] Donnell D(2009)Sexual practices of people living with HIV in South Eastern Nigeria Niger J Clin Pract 12 416-20

[9] Ndase P(2005)Micro-social structural approaches to HIV prevention: a social ecological perspective AIDS Care 17 102-13

[10] Mugo NR(2004)The social epidemiology of human immunodeficiency virus / acquired immunodeficiency syndrome Epidemiol Rev 26 22-35

[1] Grant RM(2010)Preexposure chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men N Engl J Med 363 2587-99

[2] Lama JR(2012)Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women N Engl J Med 367 399-410

[3] Anderson PL(2012)Antiretroviral Pre-exposure Prophylaxis for Heterosexual HIV Transmission in Botswana N Engl J Med 367 423-34

[4] McMahan V(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo controlled phase 3 trial Lancet 381 2083-90

[5] Liu AY(2011)Prevention of HIV-1 Infection with Early Antiretroviral Therapy N Engl J Med 365 493-505

[6] Vargas L(2012)A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: Should we be alarmed? Drug Alcohol Depend 127 65-71

[7] Baeten JM(2006)HIV status of partners of HIV positive pregnant women in different regions of Nigeria: matters arising Afr J Med Med Sci 35 125-9

[8] Donnell D(2009)Sexual practices of people living with HIV in South Eastern Nigeria Niger J Clin Pract 12 416-20

[9] Ndase P(2005)Micro-social structural approaches to HIV prevention: a social ecological perspective AIDS Care 17 102-13

[10] Mugo NR(2004)The social epidemiology of human immunodeficiency virus / acquired immunodeficiency syndrome Epidemiol Rev 26 22-35